Floatz logo

Bl-M07D1

Locally Advanced or Metastatic Digestive Tract Tumors

Sichuan Baili Pharmaceutical Co., Ltd.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

43 Active assets in the Locally Advanced or Metastatic Digestive Tract Tumors cohort.

Asset / SponsorPhaseRating
Capecitabine
China Medical University, China
Phase 3BB
Sorafenib
Sichuan Cancer Hospital and Research Institute
Phase 3BB
FLUOROURACILUM
Janssen Research & Development, LLC
Phase 3BB
Irinotecan
Pfizer
Phase 3BB
N-Acetyl-L-Cysteine
German Cancer Research Center
Phase 2B

View all 50 →

Same molecule, other indications

Bl-M07D1 is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
68 / 100
View asset →
HER2 positive breast carcinomaDormant
B
Indicative ·
60 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →